CORC  > 湖南大学
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
Surabhi Ranjan; Martha Quezado; Nancy Garren; Lisa Boris; Christine Siegel; Osorio Lopes Abath Neto; Brett J. Theeler; Deric M. Park; Edjah Nduom; Kareem A. Zaghloul
刊名BMC CANCER
2018
卷号Vol.18
关键词CTLA-4 Immune checkpoint inhibitors Immunotherapy Ipilimumab iRANO PD-1 Pseudoprogression Nivolumab
ISSN号1471-2407
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5460611
专题湖南大学
作者单位1.Neuro-Oncology Branch, Center for Cancer Research,National Cancer Institute, National Institute of Health,Bethesda,USA
2.Laboratory of Pathology, National Cancer Institute,National Institutes of Health,Bethesda,USA
3.Clinical Research Directorate/Clinical Monitoring Research Program,Leidos Biomedical Research, Inc., NCI Campus at Frederick,Frederick,USA
4.Department of Neurology and John P. Murtha Cancer Center,Walter Reed National Military Medical Center,Bethesda,USA
5.Surgical Neurology Branch,National Institute of Neurological Disorders and Stroke, National Institutes of Health,Bethesda,USA
推荐引用方式
GB/T 7714
Surabhi Ranjan,Martha Quezado,Nancy Garren,et al. Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases[J]. BMC CANCER,2018,Vol.18.
APA Surabhi Ranjan.,Martha Quezado.,Nancy Garren.,Lisa Boris.,Christine Siegel.,...&Jing Wu.(2018).Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.BMC CANCER,Vol.18.
MLA Surabhi Ranjan,et al."Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases".BMC CANCER Vol.18(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace